成人X连锁低磷血症患者脊柱附着点病变的发展
在法国罕见钙磷代谢病参考中心开展回顾性研究,纳入51例成人X连锁低磷血症(XLH)患者,间隔至少2年行两次EOS®影像,平均间隔5.7±2.31年,27例(52.9%)脊柱附着点病变进展;单因素分析中年龄较大、开始治疗年龄较大、牙科并发症、儿童期较少接受磷酸盐和/或维生素D类似物治疗及基线髋骨关节炎与进展相关,但多因素分析中无因素与进展相关;结论认为年龄似乎是进展的主要相关因素。
要点
- 51例成人XLH患者中27例(52.9%)出现脊柱附着点病变进展。
- 单因素分析中进展组年龄更大(P < .0005)、开始治疗年龄更大(P = .02)。
- 多因素分析中无因素与脊柱附着点病变进展相关。
核心结论
- 本研究证实脊柱附着点病变进展的患者比例较高,年龄似乎是进展的主要相关因素。
研究设计与样本
- 在法国罕见钙磷代谢病参考中心开展的回顾性研究,纳入2011年6月至2022年3月期间在同一中心至少间隔2年行两次EOS®影像的成人XLH患者51例(66.7%为女性,平均年龄42.1±13.4岁),两次影像平均间隔5.7±2.31年。
主要发现
- 27例(52.9%)患者观察到脊柱附着点病变进展。
- 单因素分析中,脊柱附着点病变进展的患者年龄显著更大(P < .0005)、开始治疗时年龄显著更大(P = .02)、出现牙科并发症(P = .03)、儿童期接受磷酸盐和/或维生素D类似物治疗较少(P = .06)、基线时髋骨关节炎更常见(P = .002)。
- 多因素分析中,上述因素均与脊柱附着点病变进展无关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Musculoskeletal complications are the main manifestations in adults with X-linked hypophosphatemia (XLH). Enthesopathy significantly impairs quality of life. OBJECTIVE: To identify the risk factors associated with the development and progression of spinal enthesopathies in adults with XLH. DESIGN AND SETTING: We conducted a retrospective study in the French Reference Center for Rare Diseases of the Calcium and Phosphate Metabolism. PATIENTS: Adults XLH patients with 2 EOS® imaging performed at least 2 years apart at the same center between June 2011 and March 2022. The progression of enthesopathies was defined as a new enthesopathy at least 1 intervertebral level in patients with or without presence of enthesopathy at baseline. MAIN OUTCOME MEASURES: Demographic, treatment, PHEX mutation with the progression of enthesopathies. RESULTS: Fifty-one patients (66.7% of women, mean age 42.1 ± 13.4 years) underwent 2 EOS imaging with an average interval of 5.7 (± 2.31) years.Progression of spinal enthesopathies was observed in 27 (52.9%) patients. In univariate analysis, patients with a progression of spinal enthesopathies were significantly older (P < .0005), were significantly older at treatment initiation (P = .02), presented with dental complications (P = .03), received less frequently treatment during childhood with phosphate and/or vitamin D analogs (P = .06), and presented more frequently with hip osteoarthritis (P = .002) at baseline. In multivariate analysis, none of these factors was associated with a progression of spinal enthesopathies. CONCLUSION: This study confirms the high proportion of patients with a progression of spinal enthesopathies. Age seems to be the main factor associated with progression.
引用
- Herrou J, Fechtenbaum J, Rothenbuhler A, et al. Development of Spinal Enthesopathies in Adults With X-linked Hypophosphatemia. J Clin Endocrinol Metab. 2023. PMID: 37390471. doi:10.1210/clinem/dgad383
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。